Active Ingredient History

  • Now
Reteplase, trade names include Retavase, is a thrombolytic drug, used to treat heart attacks by breaking up the clots that cause them.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No
173-527-plasminogen activator (human tissue-type), 173-l-serine-174-l-tyrosine-175-l-glutamine- | bm 06022 | bm 06.022 | bm-06.022 | human t-pa (residues 1-3 and 176-527) | rapilysin | retavase | reteplase | reteplase,recombinant | reteplase, recombinant


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue